Pedersen’s patients commonly find the side effects of GLP-1 receptor agonists being moderate and manageable, she says—but many people can’t tolerate these drugs in the least. And they ought to be made use of cautiously in people with other particular other situations, including retinal diseases, which can be worsened if blood sugar decreases